HSBC Holdings
FOLD

HSBC Holdings’s Amicus Therapeutics FOLD Stock Holding History

HSBC Holdings’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$311K Buy
+21,517
New +$308K ﹤0.01% 2436
2025
Q3 		– Sell
-65,044
Closed -$377K – 2851
2025
Q2 		$377K Buy
65,044
+14,588
+29% +$94.1K ﹤0.01% 2308
2025
Q1 		$412K Buy
50,456
+8,536
+20% +$79K ﹤0.01% 2181
2024
Q4 		$395K Buy
41,920
+18,964
+83% +$197K ﹤0.01% 2320
2024
Q3 		$247K Sell
22,956
-8,317
-27% -$90.6K ﹤0.01% 2479
2024
Q2 		$308K Buy
31,273
+809
+3% +$8.3K ﹤0.01% 2258
2024
Q1 		$359K Buy
+30,464
New +$390K ﹤0.01% 2308
2021
Q3 		– Sell
-10,340
Closed -$102K – 3041
2021
Q2 		$102K Buy
+10,340
New +$101K ﹤0.01% 2846
2021
Q1 		– Sell
-33,262
Closed -$772K – 2862
2020
Q4 		$772K Buy
+33,262
New +$680K ﹤0.01% 1882
2020
Q3 		– Sell
-12,667
Closed -$191K – 2768
2020
Q2 		$191K Buy
+12,667
New +$154K ﹤0.01% 2383
2020
Q1 		– Sell
-25,220
Closed -$247K – 2811
2019
Q4 		$247K Sell
25,220
-21,285
-46% -$195K ﹤0.01% 2692
2019
Q3 		$373K Buy
+46,505
New +$505K ﹤0.01% 2494
2018
Q2 		– Sell
-133,594
Closed -$2.01M – 2612
2018
Q1 		$2.01M Buy
+133,594
New +$2.03M ﹤0.01% 1424
2017
Q1 		– Sell
-24,543
Closed -$122K – 2272
2016
Q4 		$122K Buy
+24,543
New +$170K ﹤0.01% 2602

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

HSBC Holdings's FOLD Position: Q1 2026 in Review

HSBC Holdings opened a new position in Amicus Therapeutics (FOLD) in Q1 2026: 21,517 shares worth $311K. The stake represents ﹤0.01% of the portfolio and ranks #2436 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in FOLD as recently as Q2 2025.

HSBC Holdings first reported a position in FOLD in Q4 2016 and has held it in 14 quarters since. The position peaked at $2.01M in Q1 2018. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • HSBC Holdings held 21,517 shares of Amicus Therapeutics worth $311K as of Q1 2026.
  • Amicus Therapeutics was a new HSBC Holdings position in Q1 2026.
  • Amicus Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2436 holding.
  • HSBC Holdings first reported a position in Amicus Therapeutics in Q4 2016 and has held it in 14 quarters since.
  • HSBC Holdings's Amicus Therapeutics position peaked at $2.01M in Q1 2018.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.